Literature DB >> 17986499

The alcohol withdrawal syndrome.

A McKeon1, M A Frye, Norman Delanty.   

Abstract

The alcohol withdrawal syndrome (AWS) is a common management problem in hospital practice for neurologists, psychiatrists and general physicians alike. Although some patients have mild symptoms and may even be managed in the outpatient setting, others have more severe symptoms or a history of adverse outcomes that requires close inpatient supervision and benzodiazepine therapy. Many patients with AWS have multiple management issues (withdrawal symptoms, delirium tremens, the Wernicke-Korsakoff syndrome, seizures, depression, polysubstance abuse, electrolyte disturbances and liver disease), which requires a coordinated, multidisciplinary approach. Although AWS may be complex, careful evaluation and available treatments should ensure safe detoxification for most patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986499     DOI: 10.1136/jnnp.2007.128322

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  51 in total

1.  Genotype Differences in Sensitivity to the Anticonvulsant Effect of the Synthetic Neurosteroid Ganaxolone during Chronic Ethanol Withdrawal.

Authors:  Michelle A Nipper; Jeremiah P Jensen; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Neuroscience       Date:  2018-12-02       Impact factor: 3.590

Review 2.  Identification and management of alcohol withdrawal syndrome.

Authors:  Antonio Mirijello; Cristina D'Angelo; Anna Ferrulli; Gabriele Vassallo; Mariangela Antonelli; Fabio Caputo; Lorenzo Leggio; Antonio Gasbarrini; Giovanni Addolorato
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

Review 3.  The development and maintenance of drug addiction.

Authors:  Roy A Wise; George F Koob
Journal:  Neuropsychopharmacology       Date:  2013-10-11       Impact factor: 7.853

4.  Evaluation of a Novel Protocol for Assessment and Treatment of Alcohol Withdrawal Syndrome in Psychiatric Inpatients.

Authors:  Michael Butterfield; Lucas Thorne-Humphrey; Joji Suzuki; Nicole Herschenhous
Journal:  Am J Addict       Date:  2020-06-03

Review 5.  Ethical and legal aspects of conducting clinical trials in alcohol withdrawal syndrome.

Authors:  Vikram Reddy K; Harsha R
Journal:  J Clin Diagn Res       Date:  2014-05-15

Review 6.  Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Authors:  Patrycja Kleczkowska; Irena Smaga; Małgorzata Filip; Magdalena Bujalska-Zadrozny
Journal:  Neurotox Res       Date:  2016-08-02       Impact factor: 3.911

7.  Psychiatric symptoms and histories among people detained in police cells.

Authors:  James Ogloff; Lisa Warren; Christine Tye; Foti Blaher; Stuart Thomas
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-06-24       Impact factor: 4.328

8.  Self-disembowelment during delirium tremens: why early diagnosis is vital.

Authors:  Rachel Thomasson; Vanessa Craig; Elspeth Guthrie
Journal:  BMJ Case Rep       Date:  2016-10-24

9.  Relative potency and effectiveness of flunitrazepam, ethanol, and beta-CCE for disrupting the acquisition and retention of response sequences in rats.

Authors:  Stuart T Leonard; Lisa R Gerak; Marcus S Delatte; Joseph M Moerschbaecher; Peter J Winsauer
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

Review 10.  Agrypnia excitata.

Authors:  Federica Provini
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.